MACURITSK (Q2023575): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
(Changed an Item: Change because item Q2500969 was merged with Q253080) |
||
| Property / contained in NUTS | Property / contained in NUTS | ||
Revision as of 08:21, 29 December 2020
Project Q2023575 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MACURITSK |
Project Q2023575 in Italy |
Statements
73,298.94 Euro
0 references
97,731.92 Euro
0 references
75.0 percent
0 references
7 August 2018
0 references
6 August 2019
0 references
GENUS BIOTECH SRL
0 references
41°5'38.83"N, 14°42'19.22"E
0 references
IL PRESENTE PROGETTO SI PROPONE DI COMMERCIALIZZARE IL MACURISK KIT, OSSIA UNKIT ANALITICO PER VALUTARE LA PREDISPOSIZIONE GENETICA INDIVIDUALE A SVILUPPARE MACULOPATIE SENILI INETÃ AVANZATA CHE ASSOCIA AL PROFILO DI RISCHIO GENETICO UN PREPARATO NUTRACEUTICO DI NUOVA FORMULAZIONE (Italian)
0 references
THE AIM OF THIS PROJECT IS TO MARKET THE MACURISM KIT, I.E. UNKIT, ANALYTICAL FOR ASSESSING INDIVIDUAL GENETIC PREDISPOSITION TO DEVELOP AN ADVANCED INETHER MACULOPATHIES WHICH COMBINES WITH THE GENETIC RISK PROFILE OF A NOVEL NUTRACEUTICAL PREPARATION. (English)
0 references
THE AIM OF THIS PROJECT IS TO MARKET THE MACURISM KIT, I.E. UNKIT, ANALYTICAL FOR ASSESSING INDIVIDUAL GENETIC PREDISPOSITION TO DEVELOP AN ADVANCED INETHER MACULOPATHIES WHICH COMBINES WITH THE GENETIC RISK PROFILE OF A NOVEL NUTRACEUTICAL PREPARATION. (English)
0 references
Identifiers
B82C18000090007
0 references